Blue Owl Capital Holdings LP 13D and 13G filings for AEON Biopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 5:09 pm Sale | 2024-12-31 | 13G | AEON Biopharma, Inc. AEON | Blue Owl Capital Holdings LP | 42,352 3.810% | -4,053 (-8.73%) | Filing |
| 2024-11-14 5:05 pm Purchase | 2024-09-30 | 13G | AEON Biopharma, Inc. AEON | Blue Owl Capital Holdings LP | 46,406 8.450% | 46,406 (New Position) | Filing |